082270 — GemVax & KAEL Co Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyAdventurousSmall CapSucker Stock

Annual cashflow statement for GemVax & KAEL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-92,103	1,635	12,058	-19,604	-27,177
Depreciation
Amortisation
Non-Cash Items	87,225	4,874	-13,587	16,711	21,461
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	2,484	5,727	-4,252	-3,102	5,291
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-712	13,955	-3,467	-2,955	3,566
Capital Expenditures	-905	-10,374	-6,874	-9,090	-8,461
Purchase of Fixed Assets
Other Investing Cash Flow Items	21,186	-10,948	-21,195	15,582	-2,053
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	20,281	-21,322	-28,069	6,492	-10,514
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	78.5	3,021	-661	-5,979	7,739
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	19,889	-4,580	-32,054	-2,919	720